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ABSTRACT 
Objective: The objective of the current study is to improve the solubility of the Biopharmaceutical Classification System (BCS) Class-II drug, 
Metolazone, using various superdisintegrants. 
Methods: Starches were extracted from Sterculia foetida seed powder by water and alkali techniques i.e., sodium hydroxide at 0.1%, 0.25% and 
0.5% concentrations. Several phytochemical and physicochemical parameters were evaluated on the extracted starches. Solid dispersions of 
Metolazone were prepared by the solvent evaporation technique using plasdone K-29/32 alone and by mixing plasdone K-29/32 with Sterculia 
foetida seed starch. Various physical parameters were evaluated for the prepared solid dispersions. Tablets were prepared using Metolazone solid 
dispersions and varying concentrations of Sterculia foetida seed starch by direct compression technique. Pre and post-compression parameters 
were evaluated along with in vitro drug release studies, characterization using Scanning Electron Microscopy (SEM) and stability studies.  
Results: Phytochemical tests showed the presence of starch in all extracts. Starch prepared from 0.1% sodium hydroxide (SFS2) showed best 
physicochemical properties. In vitro dissolution studies revealed that solid dispersion MS4 containing Metolazone and plasdone K-29/32 in 1:3 
ratios showed better drug release. Formulation MPT6 containing MS5 solid dispersion with 15% w/w of SFS2 showed enhanced drug release. SEM 
studies revealed no major interactions between drugs and excipients. Accelerated stability studies showed that all tablets were stable.  
Conclusion: Sterculia foetida seed starch and plasdone K-29/32 have enhanced the solubility of Metolazone. 
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INTRODUCTION 
Solubility of drugs is an important pre-requisite in eliciting their 
pharmacological effect in the body. Most of the drugs are facing the 
problem of aqueous solubility. Enhancement of solubility of such drugs 
can be helpful for many patients. It is highly beneficial for geriatrics and 
paediatrics that prefer to take drugs through oral route [1]. The solubility 
can be enhanced by various techniques like preparation of solid 
dispersions, cyclodextrins, liposomes and fast-dissolving tablets. They 
change the properties of drugs and make them more soluble in water [2]. 
Solid dispersions are the dosage forms which have two main 
components; one is a hydrophobic drug and other a hydrophilic carrier. 
They were prepared by various techniques like physical mixing, solvent 
evaporation and fusion techniques [3]. Solid dispersions adopt many 
techniques to dissolve drug in water like making complexes, reducing 
the particle size, increasing wetting time etc [4]. 
Fast dissolving tablets (FDTs) are the formulations which releases 
the drugs immediately after taking into the mouth within seconds to 
3 min. They contain special types of ingredients called 
superdisintegrants [5]. FDTs were formulated using different 
techniques like direct compression, wet granulation, lyophilization 
etc. Superdisintegrants are the agents which make the drug 
disintegrate rapidly in water by wicking or swelling or by any other 
mechanisms [6]. Till now, several synthetic and semi-synthetic 
superdisintegrants have been used in the preparation of dosage 
forms. Recent studies have suggested that usage of natural agents as 
superdisintegrants is beneficial [7]. Natural sources are gaining 
attention in the development of pharmaceuticals nowadays. Among 
those, starches stand on top because of their varying applications in 
the development of pharmaceutical formulations. Starches were 
used as binders, bulking agents and superdisintegrants [8]. 
In the current study, an attempt was made to extract starch from of 
Sterculia foetida seed powder and to use it as superdisintegrant for 
formulating fast-dissolving tablets. Sterculia foetida belongs to the 
family Malvaceae, grows in climates of India, Philippines and 
Indonesia. Their seeds have a black coat which can be easily 
removed. The central part contains the cotyledons. They contain 
starch and various significant phytochemical constituents [9]. 
Metolazone, which is a diuretic agent was selected for the present 
study. It is a BCS (Biopharmaceutical Classification System) class-II 
drug which is poorly soluble in water. It shows the diuretic effect by 
inhibiting the sodium-chloride symporter pump which is present in 
distal convoluted tubule of nephron. This it prevents the 
reabsorption of sodium, which favours its excretion [10]. Along with 
sodium, water also gets excreted from body. This is highly beneficial 
in case of hypertensive patients who have water retention as major 
obstruction. The bioavailability of metolazone is approximately 
65%. Only 33% of the drug is bound to plasma proteins. It has an 
approximate elimination half-life of 14h. Based on pharmacokinetic 
and pharmacodynamic parameters, Metolazone is selected as drug 
of choice for present study. 
MATERIALS AND METHODS 
Materials 
Metolazone and croscarmellose sodium were gift samples from M/s. 
NATCO Pharma Ltd. (Hyderabad, India). Plasdone K-29/32 and 
microcrystalline cellulose were gift samples from Pellets Pharma Ltd 
(Hyderabad, India). Sodium hydroxide, saccharin sodium, 
magnesium stearate and talc were procured form S. D Fine Chem. 
Ltd. (Mumbai, India). Sterculia foetida seeds were procured from the 
local market (Tirumala, Andhra Pradesh, India) and were identified 
and authentified by Dr. K. Ammani, Professor, Department of Botany, 
Acharya Nagarjuna University, Guntur and a voucher specimen 
(01/2017) was preserved in the Department of Pharmaceutics, 
Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, 
Chowdavaram, Guntur, India. 
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Extraction of starch from Sterculia foetida seeds 
Sterculia foetida seed starch was isolated using aqueous and alkali 
extraction methods [11]. 5g Sterculia foetida seed flour was added 
into 100 ml distilled water, 0.1%, 0.25% and 0.5% sodium hydroxide 
solutions separately and soaked (6 h and 8 h) at room temperature 
then stirred constantly. The slurry was filtered through 212 mesh 
stainless sieve and remaining sediment was washed with distilled 
water for three times. The filtrates were combined and precipitated 
overnight at 4 °C. The supernatant was discarded and the crude 
starch was cleaned with distilled water. This step was repeated 
three times and starch cake was dried at 40 °C for 24 h in oven 
dryer. The starch was ground with a mortar and pestle. The starches 
were packed in a plastic bag and stored at room temperature. 
Phytochemical tests for Sterculia foetida seed powder and 
extracted starches 
The raw Sterculia foetida seed powder and starches extracted were 
subjected to various phytochemical tests for the identification of 
carbohydrates, proteins, alkaloids, glycosides, steroids, flavonoids 
and saponins [12]. The results were indicated in table 1. 
Evaluation of physicochemical properties of Sterculia foetida 
seed powder and extracted starches 
Various physicochemical properties like gelatinization temperature, 
pH, viscosity, swelling index, water absorption index, total microbial 
load, acidity, fluorescence, presence of oxidizing substances, 
sulphated ash, loss on drying and amylose content were evaluated 
using suitable methods [13]. 
Acidity 
One gram of starch was added to 100 ml of ethanol (70%), which 
was previously neutralized to phenolphthalein solution. This 
solution was shaken for 1h, filtered and 50 ml of the filtrate was 
titrated with 0.1M sodium hydroxide. 
Fluorescence 
500 mg of starch powder was dissolved in organic solvent, placed on 
a glass slide and was examined under UV cabinet for the presence of 
any fluorescent material. 
Oxidizing substances 
To 0.5g of the sample, 10 ml of water and 1 ml of acetic acid were 
added and stirred until a homogeneous suspension was obtained. 
0.5 ml of a freshly prepared saturated solution of potassium iodide 
was added, mixed and allowed to stand for 5 min. Non-production of 
blue or blue colour indicates the absence of oxidizing substances. 
Sulphated ash 
1-2 g of the starch was placed in an accurately weighed crucible, 
ignited and thoroughly charred. Then it is cooled and the residue 
was moistened with 1 ml of sulphuric acid. It was heated gently until 
white fumes are no longer evolved and ignited at 800 °C until black 
particles have disappeared. The crucible was cooled and few drops 
of sulphuric acid was added and heated. Then it was weighed. This 
procedure was repeated until two successive weighing doesn’t differ 
by more than 0.5 mg. 
Loss on drying 
Loss on drying is widely used to determine the moisture content of a 
sample, although occasionally it may refer to the loss of any volatile 
matter from the sample. Not more than 15% (for all starches except 
potato starch) and not more than 20% (for potato starch) of weight 
loss should be obtained. It was determined by drying 0.2g of starch 
in an oven at 105 °C. 
Test for amylose content 
To 100 mg of starch, 1 ml of ethanol and 9 ml of 1N sodium 
hydroxide were added and kept aside for overnight. The suspension 
was thoroughly mixed. The dispersed sample was transferred to a 
100 ml volumetric flask and diluted to the mark with distilled water. 
5 ml of this solution was pipetted into a 100 ml volumetric flask, 1 
ml of 1N glacial acetic acid and 2 ml of Iodine solution (0.02N) were 
added. The volume was made up to 100 ml with distilled water and 
the absorbance was measured at 620 nm. 
Preparation of metolazone solid dispersions by solvent 
evaporation method 
Solid dispersions of Metolazone were prepared using plasdone K-
29/32 in different ratios by solvent evaporation method [14]. 
Measured quantities of Metolazone and Plasdone K-29/32 were 
placed in a china dish, few ml of methanol was added and heated at 
low temperature until both gets melted. The mixture was allowed to 
evaporate by stirring. The solid mass was obtained after the solvent 
gets evaporated. The granules obtained were crushed and stored in 
desiccator for further studies. The results were given in table 3. 
Evaluation of physical parameters 
The prepared solid dispersions were evaluated for various physical 
parameters such as angle of repose, Carr’s index, Hausner's ratio, particle 
size and drug content [15]. The results were indicated in table 4. 
In vitro dissolution studies 
Dissolution studies for all solid dispersions were performed in a 
calibrated dissolution test apparatus (LABINDIA DS8000) equipped 
with paddles employing 900 ml of phosphate buffer pH 6.8 as 
dissolution medium. The paddles were operated at 75rpm and 
temperature was maintained at 37±1 °C throughout the experiment. 
The samples were withdrawn at 5, 10, 15, 20 and 30 min and 
replaced with equal volume of same dissolution medium to maintain 
the sink conditions. The amount of the drug dissolved in the 
dispersions was estimated by double-beam U. V spectrophotometer 
at 237 nm. The dissolution profiles were indicated in fig. 1. 
Preparation of metolazone tablets 
Metolazone tablets were prepared by direct compression technique 
using the solid dispersion, which showed maximum drug release. 
Sterculia foetida seed starch with the best physicochemical properties 
was selected as superdisintegrant for the preparation of tablets. The 
efficiency of starch was compared with croscarmellose sodium. The 
solid dispersion concentration was maintained constant, while the 
superdisintegrants concentration was increased. The raw materials 
were individually weighed and transferred to mortar. Using pestle, the 
components were mixed well and the prepared granules were passed 
through sieve no. 40. The granules were taken into a plastic bag and 
lubricated with talc and magnesium stearate. Then they were 
compressed as tablets under identical conditions. The compositions of 
various tablet formulations were given in table 5. 
Evaluation of pre-compression parameters 
The prepared granules were evaluated for pre-compression 
parameters such as angle of repose, Carr’s index and Hausner's ratio 
[16]. The results were given in table 6. 
Evaluation of post-compression parameters 
The compressed tablets were further evaluated for post-
compression parameters such as weight uniformity, hardness, 
friability, wetting time, dispersion test and drug content [17]. 
In vitro dissolution studies of metolazone tablets 
The 
results were given in table 7. 
Dissolution studies for Metolazone tablet formulations were performed 
in a calibrated dissolution test apparatus (USP apparatus II method) 
using 900 ml of phosphate buffer pH 6.8 as dissolution medium. The 
paddles were operated at 75rpm and temperature was maintained at 
37±1 °C throughout the experiment. Samples were withdrawn at 5, 10, 
15, 20 and 30 min and replaced with an equal volume of same 
dissolution medium to maintain the constant conditions. The amount of 
drug dissolved was estimated using U. V spectrophotometer at 237 nm. 
The dissolution profiles were given in fig. 2 and 3. 
Characterization studies 
Based on dissolution studies, the optimized formulations were 
subjected to scanning electron microscopy (SEM) analysis to know 
surface characteristics. The results were shown in fig. 4. 
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Accelerated stability studies 
Accelerated stability studies were carried out on optimized 
formulations as per International Council for Harmonisation of 
Technical Requirements for Registration of Pharmaceuticals for 
Human Use (ICH) guidelines. These studies were carried out to 
investigate the effect of temperature on the physical properties and 
drug release of the tablets [18]. The results were given in table 8. 
The optimized tablets were also evaluated for in vitro drug release 
studies and indicated in fig. 5 and 6. 
RESULTS AND DISCUSSION 
Extraction of starch from Sterculia foetida seeds 
The starches extracted from Sterculia foetida seed powder were white to 
creamish, with mild granules, free-flowing and stable in nature. 
Phytochemical screening of Sterculia foetida seed flour and 
starch extracts 
The raw Sterculia foetida seed powder and starches extracted were 
subjected to phytochemical screening. The results were indicated in 
table 1. 
Physicochemical parameters of Sterculia foetida seed flour and 
starch extracts 
Physicochemical parameters were evaluated for all the starches. The 
results were indicated in table 2. The starch SFS2 showed high 
swelling index and water absorption index which made it suitable 
for selection of solid dispersions and tablets. 
Preparation of metolazone solid dispersions by solvent 
evaporation method 
Solid dispersions of Metolazone were prepared using plasdone K-
29/32 as carrier in different ratios by the solvent evaporation 
method. The composition was given the table 3. 
Evaluation of physical parameters 
Various physical parameters for Metolazone solid dispersions were 
evaluated. All the parameters were found to be within I. P specified 
limits. The pure drug Metolazone is indicated as MP. The obtained 
results were indicated in table 4. 
In vitro dissolution studies of metolazone solid dispersions 
Formulation MS4, prepared in 1:3 ratios of Metolazone and plans 
done K-29/32 showed maximum drug release proving that solid 
dispersions prepared by the solvent evaporation technique 
increases drug release. Usage of superdisintegrants has proved to 
increase dissolution efficiency [19, 20]. Past studies suggest that 
solvent evaporation technique has proved to be successful in 
preparation of solid dispersions for solubility enhancement [21, 22]. 
The dissolution profiles of Metolazone solid dispersions were given 
in fig. 1. 
 
Table 1: Phytochemical screening of Sterculia foetida seed powder and starches (+indicates present; –indicates absent) 
Test SFSP SFS1 SFS2 SFS3 SFS4 
Carbohydrates + + + + + 
Polysaccharides + + + + + 
Proteins – – – – – 
Alkaloids + – – – – 
Glycosides – – – – – 
Steroids – – – – – 
Flavonoids + – – – – 
Saponins + – – – – 
 
Table 2: Physico-chemical properties of Sterculia foetida seed powder and starches 
Properties SFSP SFS1 SFS2 SFS3 SFS4 
Gelatinization temperature  194-200 °C 221-230 °C 232-240 °C 275-283 °C 225-232 °C 
pH 6.40 7.01 7.21 7.79 7.98 
Viscosity (in cps) 1.672 2.422 2.029 2.134 2.024 
Swelling index 39 56 79 62 55 
Water Absorption Index 186 262 294 255 240 
Total Microbial Load Absent Absent Absent Absent Absent 
Acidity Non acidified Non acidified Non acidified Non acidified Non acidified 
Fluorescence Nil Nil Nil Nil Nil 
Oxidizing Substances Nil Nil Nil Nil Nil 
Sulphated Ash (%) 0.09 0.08 0.06 0.04 0.10 
Loss on Drying (%) 3.6 3.3 2.4 6.2 4.4 
Amylose Content 5.49 4.59 18.70 13.98 11.14 
 
Table 3: Composition of metolazone solid dispersions prepared by a solvent evaporation method (*One part = 10 mg) 










Table 4: Physical parameters of metolazone solid dispersions (mean±SD; n=3) 
Solid dispersion Angle of repose (°) Carr’s index (%) Hausner's ratio Average particle size (μm) Drug content (mg) 
MP 34 22 1.27 45 09.54±1.11 
MS1 27 19 1.24 185 10.02±1.38 
MS2 24 17 1.21 176 09.98±1.27 
MS3 22 15 1.19 170 10.07±0.97 
MS4 20 12 1.15 163 10.01±1.01 
MS5 23 14 1.17 168 09.87±0.59 
MS6 23 15 1.18 172 10.11±1.19 
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Fig. 1: Drug release profiles of metolazone solid dispersions prepared by a solvent evaporation method (mean±SD; n=3) 
 
Preparation of metolazone tablets 
Metolazone tablets were prepared using the optimized solid 
dispersions (MS4) along with various concentrations of Sterculia 
foetida seed starch (SFS2) and croscarmellose sodium (CCS) by direct 
compression technique. Formulations MPT1 to MPT6 were prepared 
using 2.5 to 15% of alkali extracted starch (SFS2). Formulations MPT7 
to MPT12 were prepared using 2.5 to 15% of CCS. The formulation 
MPD contains only the solid dispersion MS4, but not any of the 
superdisintegrants. The compositions were given in table 5. 
 
Table 5: Composition of metolazone tablets with different polymer concentrations (Q. S-quantity sufficient) 
Ingredient 
(mg/tablet) 
Formulations         
MPD MPT1 MPT2 MPT3 MPT4 MPT5 MPT6 MPT7 MPT8 MPT9 MPT10 MPT11 MPT12 
MS4 Solid 
Dispersion 
40 40 40 40 40 40 40 40 40 40 40 40 40 
MCC (pH 102) 202.50 196.25 190 183.75 177.50 171.25 165 196.25 190 183.75 177.50 171.25 165 
SFS2 ----- 6.25 12.50 18.75 25 31.25 37.50 ----- ----- ----- ----- ----- ----- 
CCS ----- ----- ----- ----- ----- ----- ----- 6.25 12.50 18.75 25 31.25 37.50 
Saccharin 
Sodium 
5 5 5 5 5 5 5 5 5 5 5 5 5 
Pineapple 
Flavour 
Q. S Q. S Q. S Q. S Q. S Q. S Q. S Q. S Q. S Q. S Q. S Q. S Q. S 
Talc 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 
Magnesium 
Stearate 
1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 
Total Weight 250 250 250 250 250 250 250 250 250 250 250 250 250 
 
Evaluation of pre-compression parameters 
The pre compression parameter values obtained for various 
prepared granules were given in the table 6. The angle of repose, 
Carr’s index and Hausner’s ratio values for granules were within 
the range specified. Thus all the prepared granules were found 
to be stable and suitable for compression of tablets. 
 
Table 6: Pre-compression parameters of granules prepared for tablet formulations 
Formulation Angle of repose (°) Carr’s index (%) Hausner’s ratio 
MPD 31 21 1.22 
MPT1 27 19 1.18 
MPT2 25 17 1.16 
MPT3 23 16 1.15 
MPT4 23 15 1.13 
MPT5 22 13 1.12 
MPT6 22 12 1.12 
MPT7 28 19 1.19 
MPT8 27 18 1.17 
MPT9 25 16 1.15 
MPT10 24 14 1.14 
MPT11 24 13 1.13 
MPT12 22 12 1.12 
 
Evaluation of post compression characteristics of metolazone 
tablets 
The direct compression method was found to be suitable for 
preparation of fast dissolving tablets. Metolazone tablets were 
prepared and evaluated for post compression parameters. The 
results were given in table 7. Weight uniformity, hardness and 
friability loss of tablet formulations were within the specified limits 
and were found to be suitable for further studies. 
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Table 7: Post compression parameters of various metolazone tablet formulations (mean±SD; n=3) 
Formulation Weight uniformity (mg) Hardness 
(kg/cm2
Friability 
) (% loss) 
Wetting time (sec) Dispersion test Drug content 
(mg/tablet) 
MPD 250±1.01 3.9±0.98 0.4 244 Passed 10.08±1.16 
MPT1 249±0.91 3.3±1.17 0.3 84 Passed 09.98±0.68 
MPT2 249±1.11 3.3±0.85 0.3 62 Passed 10.05±1.18 
MPT3 250±1.20 3.2±1.06 0.2 54 Passed 10.10±1.57 
MPT4 251±1.44 3.2±1.02 0.3 33 Passed 09.90±0.82 
MPT5 250±1.32 3.3±0.75 0.3 25 Passed 10.05±0.93 
MPT6 249±0.85 3.2±1.03 0.2 16 Passed 10.07±1.04 
MPT7 251±1.04 3.4±1.09 0.3 90 Passed 09.94±1.37 
MPT8 252±0.98 3.3±0.94 0.3 71 Passed 10.18±1.64 
MPT9 251±1.13 3.3±0.73 0.2 59 Passed 10.02±0.99 
MPT10 250±0.89 3.2±1.19 0.2 40 Passed 09.91±0.77 
MPT11 250±1.51 3.2±1.35 0.3 29 Passed 10.18±1.11 
MPT12 250±0.37 3.2±1.08 0.3 20 Passed 10.09±0.85 
 
In vitro dissolution studies of metolazone tablets 
Dissolution studies were carried on Metolazone tablets using U. S. P. 
paddle method (apparatus II) with phosphate buffer pH 6.8 as 
dissolution medium by maintaining the bath temperature at 37+1 °C 
and the paddles were operated at 75rpm. The dissolution profiles of 
tablets were given in table 8. The study clearly indicated that the 
concentration of starch as superdisintegrant has highly enhanced 
the dissolution parameters of the prepared tablet formulations. 
Formulation MPT6 containing 15% w/w of SFS2 as 
superdisintegrant exhibited closer dissolution profile with that of 
formulation MPT12 prepared by 15% w/w of CCS. Natural 
superdisintegrant has showed its solubility enhancement efficiency 
similar to earlier studies [23, 24]. The superdisintegrant potency of 
the starch was probably because of the rapid uptake of water, 
followed by swelling that leads to increase in hydrostatic pressure of 
tablet that ultimately disintegrates tablets faster [25]. This study 
thus strongly supports the usage of natural starches as 
superdisintegrants which was also shown in recent studies [26]. The 
results were shown in fig. 2 and 3. 
 
 
Fig. 2: Dissolution profiles of metolazone tablets prepared by direct compression method (MPT1–MPT6) (mean±SD; n=3) 
 
 
Fig. 3: Dissolution profiles of Metolazone tablets prepared by direct compression method (MPT7 – MPT12) (mean±SD; n=3) 
 
Characterization of metolazone fast dissolving tablets 
SEM studies 
Scanning electron microscopy images were taken for Metolazone pure 
drug, SFS2, CCS, plasdone K-29/32, a blend of Metolazone with 
plasdone K-29/32, Metolazone with plasdone K-29/32 and SFS2 and 
Metolazone with plasdone K-29/32 and CCS. Metolazone pure drug 
exhibited crystalline form. The SFS2 starch exhibited spherical starch 
grains without any mucilage/resinous coverage. Plasdone K-29-32 
exhibited clear granular structure. CCS exhibited blunt tubular shaped 
crystals. The SEM image of Metolazone with plasdone K-29/32 clearly 
exhibited uniform mixing of drug with granules. The SEM image of 
Metolazone with plasdone K-29/32 and SFS2 showed complete 
dispersion of drug with polymers, whereas Metolazone with plasdone 
K-29/32 and CCS showed uniform dispersion of drug with blunt 
tubular crystals of CCS. The detailed SEM images were shown in fig. 4. 
Doppalapudi et al. 
Int J App Pharm, Vol 12, Issue 4, 2020, 144-151 
149 
 
Fig. 4: SEM images: (A) Metolazone drug (B) SFS2 (C) Plasdone K-29/32 (D) CCS, (E) A blend of Metolazone with plasdone K-29/32 (F) A 
blend of Metolazone with plasdone K-29/32 and SFS2 (G) A blend of Metolazone with plasdone K-29/32 and CCS SFS2–Sterculia foetida 
seed starch extracted by 0.1% sodium hydroxide; CCS–Croscarmellose sodium 
 
Accelerated stability studies of metolazone fast dissolving tablets 
The fast dissolving tablets MPT6 and MPT12 containing Metolazone 
with MS4 solid dispersion in ratio of 1:3 mixed with SFS2 and CCS in 
15% w/w respectively showed good in vitro dissolution and so was 
subjected to accelerated stability studies. The results were indicated 
in table 8. 
No visible and physical changes were observed in the fast dissolving 
tablets after storage. Weight uniformity, hardness, friability, wetting 
time, dispersion test and drug content were found to be uniform 
before and after storage at different conditions. It was also observed 
that there was no significant change in drug release from the FDTs 
and was indicated in fig. 5 and 6. Thus the drug release 
characteristics of FDTs designed were found to be quite stable. 
 
Table 8: Post compression parameters of metolazone fast dissolving tablet formulations (MPT6 and MPT12) under accelerated stability 
conditions (mean±SD; n=3) 
Formulation Storage condition Hardness 
(kg/cm2
Friability 
) (% loss) 




MPT6 Before Storage 3.2±1.03 0.2 Passed 16 10.07±1.04 
25±2 °C, 60±5% RH 3.2±1.37 0.3 Passed 17 10.05±1.14 
40±2 °C, 75±5% RH 3.2±1.18 0.2 Passed 17 10.06±1.23 
MPT12 Before Storage 3.2±1.08 0.3 Passed 20 10.09±0.85 
25±2 °C, 60±5% RH 3.3±1.17 0.3 Passed 22 10.11±0.99 
40±2 °C, 75±5% RH 3.2±1.49 0.3 Passed 21 10.10±1.20 
 
 
Fig. 5: Dissolution profiles of metolazone fast dissolving tablet formulation (MPT6) before and after storage at different conditions 
(mean±SD; n=3) 
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The formulation MPT6 prepared with Metolazone solid dispersions 
using Plasdone K-29/32 along with Sterculia foetida seed starch 
(15%w/w) extracted using 0.1% sodium hydroxide. Similar 
dissolution profile was observed for formulation, MPT12 containing 
Metolazone solid dispersion (MS4) along with 15%w/w of CCS. The 
formulations MPT6 and MPT12 were also found to be stable even 
when subjected to accelerated stability studies. Based on above 
studies, it was concluded that Metolazone fast dissolving tablets 
prepared by Sterculia foetida seed starch extracted from 0.1% 
sodium hydroxide showed rapid drug release. 
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